Cargando…
Modeling dynamics and alternative treatment strategies in acute promyelocytic leukemia
Acute Promyelocytic Leukemia (APL) is a rare and potentially lethal condition in which risk-based therapy often leads to better outcomes. Because of its rarity and relatively high overall survival rate, prospective randomized trials to investigate alternative APL treatment schedules are challenging....
Autores principales: | Yoshinari, Gerson Hiroshi, Fassoni, Artur César, Mello, Luis Fernando, Rego, Eduardo M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695187/ https://www.ncbi.nlm.nih.gov/pubmed/31415632 http://dx.doi.org/10.1371/journal.pone.0221011 |
Ejemplares similares
-
Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia
por: Bassi, Sarah Cristina, et al.
Publicado: (2012) -
Epidemiology and Treatment of Acute Promyelocytic Leukemia in Latin America
por: Rego, E.M., et al.
Publicado: (2011) -
The results of the International Consortium on Acute Promyelocytic Leukemia: a 'proof of concept' of networking as a strategy to improve the outcome of treatment of hematological malignancies in developing countries
por: Rego, Eduardo Magalhães
Publicado: (2013) -
Acute Promyelocytic Leukemia
por: Thomas, Xavier, et al.
Publicado: (2020) -
The Guidelines Project: Brazilian guidelines for acute promyelocytic
leukemia
por: Ruiz, Milton Artur
Publicado: (2014)